Page last updated: 2024-10-24

induction of positive chemotaxis

Definition

Target type: biologicalprocess

Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical. [GOC:ai]

Induction of positive chemotaxis is a fundamental biological process by which cells move towards higher concentrations of attractant molecules. This directed movement is crucial for various physiological functions, including immune responses, development, and wound healing. The process involves a complex interplay of signaling pathways, cytoskeletal rearrangements, and directional movement.

Here is a detailed breakdown of the process:

1. **Chemoattractant Detection:** Cells express specific receptors on their surface that can bind to chemoattractant molecules. When an attractant binds to its receptor, it triggers a signal transduction cascade.

2. **Signal Transduction:** The binding event activates intracellular signaling pathways, typically involving G protein-coupled receptors (GPCRs) and second messengers like cAMP or Ca2+. These signaling pathways can lead to the activation of downstream effector proteins.

3. **Cytoskeletal Rearrangements:** Activated effector proteins influence the organization of the cytoskeleton, particularly the actin filaments. Actin polymerization and depolymerization create protrusions (lamellipodia and filopodia) at the leading edge of the cell, while the rear end of the cell contracts.

4. **Directional Movement:** The coordinated action of protrusions and contractions drives the cell towards the higher concentration of chemoattractant. This movement involves the interplay of motor proteins like myosin, which interact with actin filaments to generate force.

5. **Polarity Establishment:** Positive chemotaxis requires the establishment of a polarized cell, with a defined front and rear end. This polarity is often driven by gradients of signaling molecules and cytoskeletal components, creating a directional bias for cell movement.

6. **Adaptation and Desensitization:** To prevent over-stimulation and maintain responsiveness, cells have mechanisms to adapt to the presence of attractants. This involves desensitization of receptors and downregulation of signaling pathways, ensuring that cells can respond to new gradients of attractants.

Overall, the induction of positive chemotaxis is a highly regulated and dynamic process that involves intricate interactions between signaling pathways, cytoskeletal rearrangements, and cell movement. This sophisticated mechanism allows cells to navigate their environment effectively and respond to external stimuli.
'
"

Proteins (5)

ProteinDefinitionTaxonomy
Placenta growth factorA placenta growth factor that is encoded in the genome of human. [PRO:DNx, UniProtKB:P49763]Homo sapiens (human)
Stromal cell-derived factor 1A stromal cell-derived factor 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P48061]Homo sapiens (human)
Advanced glycosylation end product-specific receptorAn advanced glycosylation end product-specific receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15109]Homo sapiens (human)
Vascular endothelial growth factor AA vascular endothelial growth factor A, long form that is encoded in the genome of human. [PRO:DNx, UniProtKB:P15692]Homo sapiens (human)
Interleukin-8An interleukin-8 that is encoded in the genome of human. [PMID:15623624, SALO:AJ]Homo sapiens (human)

Compounds (20)

CompoundDefinitionClassesRoles
quinolinic acidpyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.

quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.

Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
diclofenacdiclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
amino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
indomethacinindometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic;
xenobiotic metabolite
tolmetintolmetin : A monocarboxylic acid that is (1-methylpyrrol-2-yl)acetic acid substituted at position 5 on the pyrrole ring by a 4-methylbenzoyl group. Used in the form of its sodium salt dihydrate as a nonselective nonsteroidal anti-inflammatory drug.

Tolmetin: A non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL) similar in mode of action to INDOMETHACIN.
aromatic ketone;
monocarboxylic acid;
pyrroles
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
4-phenylphenol4-phenylphenol: RN given refers to cpd without isomeric designation

biphenyl-4-ol : A member of the class of hydroxybiphenyls that is biphenyl carrying a hydroxy group at position 4.
hydroxybiphenyls
ibufenacibufenac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 4-isobutylphenyl group. Although it was shown to be effective in treatment of rheumatoid arthritis, the clinical use of ibufenac was discontinued due to hepatotoxic side-effects.

ibufenac: used in the treatment of rheumatism; also possesses antipyretic properties; minor descriptor (75-84); on-line & Index Medicus search PHENYLACETATES (75-84); RN given refers to parent cpd
monocarboxylic acidEC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
hepatotoxic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
4-phenylbenzoic acid4-phenylbenzoic acid: RN given refers to 4-carboxylic cpd
matrinealkaloid
ibuprofen, (r)-isomeribuprofen
ketoprofen
chalconetrans-chalcone : The trans-isomer of chalcone.chalconeEC 3.2.1.1 (alpha-amylase) inhibitor
2-anilinophenylacetic acid2-anilinophenylacetic acid: structure in first source
amentoflavonebiflavonoid;
hydroxyflavone;
ring assembly
angiogenesis inhibitor;
antiviral agent;
cathepsin B inhibitor;
P450 inhibitor;
plant metabolite
4-hydroxychalcone4-hydroxychalcone : A member of the class of chalcones that is trans-chalcone substituted by a hydroxy group at position 4.

4-hydroxychalcone: structure in first source
chalcones;
phenols
antihypertensive agent;
plant metabolite
phenyl-3-methoxy-4-hydroxystyryl ketonephenyl-3-methoxy-4-hydroxystyryl ketone: structure given in first source
vilazodonevilazodone : A 1-benzofuran that is 5-(piperazin-1-yl}-1-benzofuran-2-carboxamide having a (5-cyanoindol-3-yl)butyl group attached at position N-4 on the piperazine ring. Used for the treatment of major depressive disorder.1-benzofurans;
indoles;
monocarboxylic acid amide;
N-alkylpiperazine;
N-arylpiperazine;
nitrile
antidepressant;
serotonergic agonist;
serotonin uptake inhibitor
proanthocyanidin a1procyanidin A1: from aqueous extract of peanut skin; structure in first sourceflavonoid oligomer
fps-zm1FPS-ZM1: a neuroprotective agent and RAGE receptor antagonist; structure in first source
phosphomannopentaose sulfatephosphomannopentaose sulfate: structure in first source
n(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithineN(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithine: RN given for (L)-isomer; structure in first source